Oxidative Stress Assay Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

Oxidative Stress Assay Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028


The global oxidative stress assay market size reached US$ 789.5 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,368.4 Million by 2028, exhibiting a growth rate (CAGR) of 9.6% during 2022-2028.



Oxidative stress is a health condition wherein excessive production of oxygen-derived free radicals within a cell or organism overwhelms the intrinsic antioxidant defenses. It causes oxidative damage to proteins, lipids and nucleic acids, which can further lead to the development of cancer, asthma, ischemia, diabetes, and cardiovascular and neurodegenerative diseases. It is assessed using a number of assays that help healthcare researchers gain a better understanding of the mechanisms and responses of the condition.



Free radicals can be produced due to biological factors, unhealthy dietary habits and air pollution. This, in confluence with the rising number of individuals who smoke and consume alcohol, is escalating the risk of developing oxidative stress, which, in turn, is strengthening the market growth. Apart from this, the development of various pathologic conditions and acceleration of the aging process on account of oxidative stress is also bolstering the market growth. Furthermore, the growing biopharmaceutical industry, increasing investments in the research and development (R&D) activities and technological advancements, such as high-content screening for drug discovery, are acting as other major factors stimulating the market growth. Moreover, oxidative stress is also being considered as a major factor contributing to the severity of the coronavirus disease (COVID-19). It is also being evaluated as a probable cause of multi-organ failure among patients. The ongoing studies on the interrelation between the disease and oxidative stress are expected to positively influence the market growth.



Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global oxidative stress assay market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, technology, test type and end user.



Breakup by Product:



Reagents and Consumables

Instruments

Services



Breakup by Technology:



ELISA (Enzyme-Linked Immunosorbent Assay)

Flow Cytometry

Chromatography

Microscopy

High-Content Screening

Label-Free Detection

Others



Breakup by Test Type:



Indirect Assays

Protein-Based Assays

Lipid-Based Assays

Nucleic Acid-Based Assays

Antioxidant Capacity Assays

Glutathione Assays

Ascorbic Acid Assays

Cell-Based Exogenous Antioxidant Assays

Enzyme-Based Assays

Reactive Oxygen Species-Based Assays



Breakup by End User:



Pharmaceutical Industry

Research Institutes

Others



Breakup by Region:



North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa



Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Abcam PLC, AMS Biotechnology (Europe) Ltd., Biovision Inc. (Boai NKY Medical Holdings Ltd.), Cell Biolabs Inc., Enzo Biochem Inc., ImmunoChemistry Technologies LLC, Merck KGaA, Oxford Biomedical Research, Promega Corporation, Qiagen N.V. and Thermo Fisher Scientific Inc.



Key Questions Answered in This Report:

How has the global oxidative stress assay market performed so far and how will it perform in the coming years?

What has been the impact of COVID-19 on the global oxidative stress assay market?

What are the key regional markets?

What is the breakup of the market based on the product?

What is the breakup of the market based on the technology?

What is the breakup of the market based on the test type?

What is the breakup of the market based on the end user?

What are the various stages in the value chain of the industry?

What are the key driving factors and challenges in the industry?

What is the structure of the global oxidative stress assay market and who are the key players?

What is the degree of competition in the industry?


1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Oxidative Stress Assay Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Reagents and Consumables
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Instruments
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Services
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Technology
7.1 ELISA (Enzyme-Linked Immunosorbent Assay)
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Flow Cytometry
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Chromatography
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Microscopy
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 High-Content Screening
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Label-Free Detection
7.6.1 Market Trends
7.6.2 Market Forecast
7.7 Others
7.7.1 Market Trends
7.7.2 Market Forecast
8 Market Breakup by Test Type
8.1 Indirect Assays
8.1.1 Market Trends
8.1.2 Major Types
8.1.2.1 Protein-Based Assays
8.1.2.2 Lipid-Based Assays
8.1.2.3 Nucleic Acid-Based Assays
8.1.3 Market Forecast
8.2 Antioxidant Capacity Assays
8.2.1 Market Trends
8.2.2 Major Types
8.2.2.1 Glutathione Assays
8.2.2.2 Ascorbic Acid Assays
8.2.2.3 Cell-Based Exogenous Antioxidant Assays
8.2.3 Market Forecast
8.3 Enzyme-Based Assays
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Reactive Oxygen Species-Based Assays
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by End User
9.1 Pharmaceutical Industry
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Research Institutes
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Others
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Abcam PLC
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 AMS Biotechnology (Europe) Ltd.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.3 Biovision Inc. (Boai NKY Medical Holdings Ltd.)
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.4 Cell Biolabs Inc.
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.5 Enzo Biochem Inc.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 ImmunoChemistry Technologies LLC
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7 Merck KGaA
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Oxford Biomedical Research
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.9 Promega Corporation
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.10 Qiagen N.V.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.11 Thermo Fisher Scientific Inc.
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings